Considering the widespread use of assisted reproductive techniques (ART), DNA methylation of specific genes involved in spermatogenesis achieves increasingly clinical relevance, representing a possible explanation of increased incidence of syndromes related to genomic imprinting in medically assisted pregnancies. Several trials suggested a relationship between male sub-fertility and sperm DNA methylation, although its weight on seminal parameters alteration is still a matter of debate. To evaluate whether aberrant sperm DNA methylation of imprinted genes is associated with impaired sperm parameters. Meta-analysis of controlled clinical trials evaluating imprinted genes sperm DNA methylation comparing men with idiopathic infertility to fertile controls. Twentyfour studies were included, allowing a meta-analytic evaluation for H19, MEST, SNRPN, and LINE-1. When a high heterogeneity of the results was demonstrated, the random effect model was used. H19 methylation levels resulted significantly lower in 879 infertile compared with 562 fertile men (7.53%, 95% CI: 5.14-9.93%, p < 0.001), suggesting a 9.91-fold higher risk ratio to show aberrant sperm DNA methylation (95% CI: 5.55-17.70, p < 0.001, I 2 = 19%) in infertile men. The mean MEST methylation level was significantly higher in 846 infertile compared with 353 fertile men (3.35%, 95% CI: 1.41-5.29%, p < 0.001), as well as for SNRPN comparing 301 infertile men with 124 controls (3.23%, 95% CI: 0.75-5.72%, p < 0.001). LINE-1 methylation levels did not differ between 291 infertile men and 198 controls (0.44%, 95% CI: À2.04-1.16%, p = 0.63). The meta-analytic approach demonstrated that male infertility is associated with altered sperm methylation at H19, MEST, and SNRPN. Although its role in infertility remains unclear, sperm DNA methylation could be associated with the epigenetic risk in ART. In this setting, before proposing this analysis in clinical practice, an accurate identification of the most representative genes and a cost-effectiveness evaluation should be assessed in ad hoc prospective studies.
INTRODUCTION
The incidence of male infertility accounts for about the 50% of all infertile couples, although in the vast majority of cases the pathogenesis remains unknown. Assisted reproductive techniques (ART) are largely used, allowing infertile men to father their own children. However, a potential risk of transmission/induction of genetic/epigenetic alterations with ART exists, in particular when more intrusive methodologies are applied, such as intra-cytoplasmatic sperm injection (ICSI). Indeed, an increased frequency of several diseases is reported after ICSI, such as Angelman, Beckwith-Wiedemann, SilverRussell and Prader-Willi syndromes (Cox et al., 2002; DeBaun et al., 2003; Gicquel et al., 2003; Gosden et al., 2003; Maher et al., 2003; Orstavik et al., 2003) . Although these diseases recognize different genetic causes, the role of sperm epigenetic aberrations has been proposed, moving the scientific interest on the relationship between genomic imprinting and fertility. ICSI is characterized by selection of gametes and culture of embryos in the early stage of their development when the genetic makeup is relatively vulnerable to external influences (DeBaun et al., 2003) . However, whether these syndromes arise from ART itself or from pre-existing epigenetic aberrations in gametes is still unclear.
The term epigenetics refers to the study of heritable modifications in gene function at the mitotic and/or meiotic level, not justified by changes in DNA sequence (Carrell, 2012) . Epigenetics play a well-established role in several physiological conditions, such as aging (Liu & Rando, 2011 ) and reproduction (Krausz et al., 2015) , as well as in pathological conditions, such as cancer (Herceg & Vaissiere, 2011) and environment-induced changes (Leenen et al., 2016) . On the contrary, although largely debated in the literature, the link between epigenetics and male infertility is far to be elucidated. During the complex human fertilization process, spermatozoa is required to traverse several hostile barriers, such as the female reproductive tract, the cumulus oophorus and the zona pellucida (Yanagimachi, 2005) . To reach its target, the spermatozoa is a highly-specialized cell, with specific architecture and peculiar functions in order to obtain a successful embryogenesis. Epigenetic changes in the sperm cell could affect sperm functions at different levels, such as histones removal, chemical modifications of histones structure or DNA methylation (Carrell, 2012) .
DNA methylation is only one of the most studied epigenetic mechanisms. Genome methylation takes place during embryonal development and it is involved in several physiological processes, such as genomic imprinting (Li et al., 1993) , X-chromosome inactivation (Beard et al., 1995) and differential gene expression (Eden & Cedar, 1994) . This reversible and heritable process is characterized by a covalent chemical modification, occurring in cytosine-phosphate-guanine (CpG) dinucleotides found at high concentrations near to the gene promoters (Portela & Esteller, 2010) . The 'CpG islands' are located in differently methylated regions (DMR) of genes and their methylation differs among the paternal and maternal alleles, influencing gene transcription (Portela & Esteller, 2010) . After fertilization, the paternal alleles are actively demethylated, whereas the maternal DNA undergoes passive demethylation (Smallwood et al., 2011) . In this way, in germ cells both maternal and paternal germ lines are reset and methylation could restart (Smallwood & Kelsey, 2012) . This represents the imprinting reprogramming that interests every cell (Canovas & Ross, 2016) . Thereafter, the first phases of spermatogenesis are characterized by an intense reorganization (Santos & Dean, 2004) involving DNA methylation, which is maintained during meiosis and further gamete development, affecting only specific genes (Kerjean et al., 2000) . This process represents the epigenetic reprogramming phase, in which each cell develops the proper (Canovas & Ross, 2016) . The so called 'imprinted genes' escape epigenetic reprogramming after fertilization, leading to the maintenance of sperm aberrant DNA methylation into the developing embryo (El Hajj et al., 2011) . The persistence of parent-specific germline patterns could justify the epigenetic flews involvement on potential risk to offspring during ART (Tian et al., 2014) . In this context, several studies documented a strong association of DNA methylation alterations of specific imprinted genes in spermatozoa of men with idiopathic infertility (Camprubi et al., 2012) . In particular, comparing infertile with fertile men, an increased odds ratio of imprinting aberrations in two specifically imprinted genes, H19 and mesoderm-specific transcript (MEST) was demonstrated. (Klaver & Gromoll, 2014) . In addition, an association between infertility and aberrant methylation on non-imprinted genes was found (Houshdaran et al., 2007) . All these data increased the scientific interest on the analysis of sperm DNA methylation as a valuable, non-invasive diagnostic marker of infertility.
The present meta-analysis was designed to evaluate a possible connection among sperm aberrant DNA methylation in imprinted genes and male infertility, with particular attention to possible implications of epigenetic assessment in clinical practice.
MATERIALS AND METHODS
A meta-analysis according to the Cochrane Collaboration and PRISMA statement (Moher et al., 2010 (Moher et al., , 2011 was performed.
Data sources and searches
We conducted a comprehensive literature search for Englishlanguage articles in MEDLINE (PubMed), EMBASE, and Cochrane Library. The search strategy provided the use of the following words: male infertility, oligozoospermia, asthenozoospermia, teratozoospermia, oligoasthenozoospermia, oligoteratozoospermia, asthenoteratozoospermia, oligoasthenoteratozoospermia (OAT), DNA methylation, imprinted genes, H19, CREM, IGF2, DAZL, PEG3, CREM, SNRPN, using the Boolean functions AND and OR.
Study selection and inclusion criteria

Types of studies
Controlled clinical trials comparing men with idiopathic male infertility to fertile controls were evaluated. Randomization was not considered as inclusion criterion of the research strategy, because this meta-analysis did not evaluate a treatment-related efficacy.
Type of participants
Infertile and fertile men were considered. In particular, men with idiopathic infertility or alterations in the semen analysis were considered in the study group. All semen abnormalities (from mild oligozoospermia to severe oligoasthenoteratozoospermia) were considered eligible. Men with azoospermia or semen samples obtained by biopsies in azoospermic patients were excluded, in order to evaluate only sperm methylation, i.e. in male gametes used to obtain spontaneous or assisted conception. On the other hand, men without semen analyses alterations, donors or volunteers were considered as controls.
Type of interventions
No treatment was considered in this meta-analysis.
Data collection process and quality
Two authors (SdV and EM) extracted the abstracts from all studies found through the literature search. All abstracts were evaluated for inclusion criteria, extracting data from each study considered eligible, with regard to study design, year of publication and number of included/excluded subjects. Furthermore, DS extracted study subjects' demographics, underlying diseases, the imprinted gene evaluated, the methylation level, as well as the proportion of men with aberrant methylation.
All controlled studies evaluating the methylation level in different imprinted genes were considered eligible. Considering the high number of known imprinted genes and the different clusters of genes evaluated in each study, a unique comprehensively analysis was not possible. Thus, we performed sub-group metaanalyses dividing the cohort of papers according to the imprinted gene evaluated.
DS and GS performed quality control checks on extracted data.
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Summary measures
The primary outcome was the methylation level in both groups of men, expressed as mean percentageAEstandard deviation (SD). The difference of the primary outcome between infertile and fertile men was calculated separately for each imprinted gene evaluated.
Secondary outcome was the proportion of aberrant DNA methylation in infertile and fertile men, expressed as risk ratio. This endpoint was calculated only when reported in the original article.
Data synthesis and analysis
The meta-analysis was conducted using the REVIEW MANAGER (REVMAN) 5.3 software (Version 5.3.1 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, London, UK). Data were combined using the fixed effect model. Weighted mean differences and 95% confidence intervals were estimated for each endpoint. Heterogeneity among results of different studies was examined by inspecting both the scatter in the data points and the overlap in their confidence intervals and by performing Chi-square tests and I 2 statistics. The I 2 statistics express which proportion of the observed variance reflects real differences in effect size. It is a measure of inconsistency across the findings of the studies, not a measure of the real variation across the underlying true effects. When I 2 was significantly high, the analysis was repeated using the random effect model, providing a more conservative estimation of the difference of mean percentage of methylation level in fertile and infertile men.
Values of p < 0.05 were considered statistically significant.
RESULTS
A total of 920 studies were found from the literature search and, after abstract evaluation, 81 studies were further assessed for the inclusion criteria (Fig. 1) . Fifty-seven studies were excluded and 24 were included in the final analysis ( Fig. 1) (Marques et al., 2004 (Marques et al., , 2008 Boissonnas et al., 2010; Hammoud et al., 2010; Navarro-Costa et al., 2010; Poplinski et al., 2010; El Hajj et al., 2011; Minor et al., 2011; Nanassy & Carrell, 2011a,b; Sato et al., 2011; Ankolkar et al., 2012; Camprubi et al., 2012; Li et al., 2013 Li et al., , 2016 Montjean et al., 2013 Montjean et al., , 2015 Botezatu et al., 2014; , Klaver & Gromoll, 2014; Richardson et al., 2014; Tian et al., 2014; Laurentino et al., 2015; Dong et al., 2016; Xu et al., 2016) . Table 1 summarizes the main characteristics of included studies. Nine studies (37.5%) enrolled men with oligozoospermia (<20 millions of sperm), whereas seven (29.25%) with OAT and seven (29.25%) with idiopathic infertility.
H19
Nineteen of 24 studies (79.2%) evaluated the DNA methylation at the H19 DMR, although only 18 of these reported the methylation levels, for a total of 879 infertile patients and 562 fertile controls. The mean difference of methylation levels was significantly lower in infertile than fertile men (2.94%, 95% CI: 2.44-3.44%, p < 0.001). Considering the high heterogeneity (I 2 = 92%) of the result, the analysis was repeated using the random effect model providing similar significant results (7.53%, 95% CI: 5.14-9.93%, p < 0.001) (Fig. 2) . Considering this subgroup, 11 studies reported the proportion of men with aberrant DNA methylation on the H19 DMR. The meta-analysis suggested that infertile men had a 9.91-fold higher risk ratio than controls to show aberrant DNA methylation (95% CI: 5.55-17.70, p < 0.001, I 2 = 19%) (Fig. 3) .
LINE-1 LINE-1 elements comprise about the 17% of the human genome and represent a proxy indicator of global genomic methylation. Only seven of 21 studies (33.3%) evaluated the global methylation at LINE-1 level, for a total of 291 patients and 198 fertile controls. The methylation levels were not significantly lower in the infertile men compared with fertile controls (0.46%, 95% CI: À0.06-0.97%, p = 0.08). Considering the elevated heterogeneity (I 2 = 87%), a random effect model was used, confirming the lack of significant difference (0.44%, 95% CI: À2.04-1.16%, p = 0.63). Only 2 studies evaluated the proportion of aberrant methylation in men enrolled, preventing the meta-analysis of the risk ratio.
MEST Eleven of 24 studies (45.8%) evaluated the maternal imprinting at DMR of MEST, for a total of 846 infertile and 353 fertile men. The DNA methylation level was significantly higher in infertile compared with fertile men (3.52%, 95% CI: 3.39-3.64%, p < 0.001) (Fig. 4) . A high heterogeneity was present (I 2 = 99%) and the random effect model confirmed the difference (3.35%, 95% CI: 1.41-5.29%, p < 0.001) (Fig. 4) . Considering this subgroup, six studies reported the proportion of men with aberrant DNA methylation on the MEST DMR. The comprehensive evaluation of these papers did not reveal a significant increased risk of aberrant methylation on MEST (0.00 95% CI: À0.03-0.04, p = 0.900, I 2 = 0%) (Fig. 5) .
SNRPN
Only five studies (20.8%) evaluated the imprinting at DMR SNRPN, for a total of 301 infertile and 124 fertile men. The mean methylation level was significantly higher in infertile than fertile Only 1 study evaluated the proportion of aberrant methylation in men enrolled, preventing the meta-analysis of the risk ratio (Fig. 6 ).
Other genes BRDT, CFTC-6, CREM, DAZL, FAM50B, GNAS, GTL2, IGF2, KCNQ1OT1, LIT1, MEG3, PEG3, RHOX, and ZAC were further evaluated by the studies included in the meta-analysis. However, none of these genes was evaluated by more than two studies, not allowing the meta-analytic evaluation.
DISCUSSION
Here, we demonstrate that male infertility is associated to H19 reduced sperm DNA methylation and to MEST and SRNPN increased methylation. This comprehensive evaluation suggests that the assessment of aberrant methylation of imprinted genes could be considered as an important marker in the diagnostic flowchart of male subfertility, although properly prospectively designed clinical trials are needed.
With our meta-analytic approach, we confirm the association of DNA methylation state in male infertility. Previously, it was demonstrated an increased odds ratio of aberrant DNA methylation on H19 and MEST in infertile men compared to fertile controls (3.4, 95% CI: 1.98-5.84, p < 0.001 and 14.62, 95% CI: 7.34-29.12, p < 0.001, respectively) (Klaver & Gromoll, 2014) . However, the odds ratio remains a mathematical tool, which could not be directly translate in an increased risk in clinical practice. Here, we demonstrate that male infertility is characterized by about ninefold increased risk of aberrant DNA methylation on H19 DMR compared with controls. This is because of a 700 Andrology, 2017, 5, 695-703 reduction in methylation level of the paternal allele of this gene. Similarly, MEST shows an increased methylation level in the maternal allele. These results could open new perspectives in research and clinical practice and properly designed clinical trials could be useful to identify the usefulness of a threshold for both H19 and MEST methylation during ART processes.
H19 is the imprinted gene most studied in male infertility. It is a 2.7 kilobase gene located on the chromosome 11p15.5, including five exons and four introns (Brannan et al., 1990) . H19 encodes for both an untranslated cytoplasmatic RNA, involved in RNA processing and in protein transport/synthesis (Zhang & Tycko, 1992) , and a putative 29K protein (Leibovitch et al., 1991) . In humans, H19 is expressed in a limited number of organs during a restricted period of fetal life, whereas its expression in adult tissues is limited to skeletal and cardiac muscle cells (Zhang & Tycko, 1992) . During fetal life, H19 is essential in fetal growth and development, when tissue differentiation is extremely active (Brannan et al., 1990) . On the contrary, H19 is silent in undifferentiated embryonal tumor cell models (Pachnis et al., 1984) . These different patterns of activation suggest that H19 is primarily involved in tissue differentiation, acting primarily on cell growth arrest (Zhang & Tycko, 1992) . MEST is located on chromosome 7q31.3, encoding for a member of the alpha/ beta hydrolase superfamily (Kosaki et al., 2000) . Although it is involved in embryonic development, adipocyte differentiation and angiogenesis processes, the exact molecular action of the MEST product is still unknown (Mayer et al., 2000; Jung et al., 2011) . The altered methylation on MEST gene was widely evaluated in association with specific cancers in animal models (Rajender et al., 2011) . Physiologically, H19 is methylated (repressed) on the paternal allele and unmethylated (expressed) on the maternal allele (Bartolomei et al., 1991) . On the contrary, MEST is monoallelically expressed from the paternal allele (Kosaki et al., 2000) .
The altered methylation of the paternally imprinted gene H19 has been already proposed to be associated with male infertility in case-control studies (Marques et al., 2008) . In particular, both sperm concentration and motility seem to be the semen parameters mostly influenced by H19 hypo/unmethylation (Dong et al., 2016) . Indeed, a significant positive correlation was documented between H19 methylation and sperm number in oligozoospermic subjects (r = 0.42, p = 0.003), as well as with sperm motility in asthenozoospermia (r = 0.37, p = 0.007) (Dong et al., 2016) . Here, we confirm that men with infertility present lower methylation and consequently higher H19 paternal allele expression potential compared with fertile controls. Moreover, the H19 gene contains three different DMRs, two related to the near IGF2 gene and one to H19 itself. Thus, IGF2 and H19 are physically linked genes and their reciprocal expression is controlled by an alternate allele imprinting (paternal for IGF2 and maternal for H19). Only one trial suggested the relationship between IGF2 and male infertility, limiting the possibility to comprehensively evaluate this new association.
The incomplete, monoallelic presentation of these genes should be considered in the pathogenetic occurrence of several diseases related to ART. In particular, Beckwith-Wiedemann syndrome is because of paternal disomy of the chromosome 11, although the 60% of sporadic cases are characterized by an altered imprinting of H19 (Henry et al., 1991; Maher et al., 2003) . Similarly, other studies reported an increased incidence of Angelman syndrome in children born after ART (Cox et al., 2002; Gosden et al., 2003) . This is a rare condition affecting about one on 15000 newborns, mainly characterized by a deletion on chromosome 15. However, in case series, the occurrence of Angelman syndrome after ART was not related to genomic deletion but to aberrant DNA methylation on SNRPN (Manning et al., 2000) . This gene is normally maternal methylated and paternal unmethylated. The altered methylation level found in infertile men suggests that the previous existence of epigenetic modification could be considered a marker for possible further imprinting error during fertilization, possibly leading to the onset of these syndromes. Several authors proposed that ICSI predisposes to abnormal imprinting, as demonstrated in animal models (Khosla et al., 2001; Young et al., 2001) . This meta-analysis identified a significant association of altered sperm DNA methylation on H19, MEST, and SNRPN with male infertility. Thus, considering that these men represent the typical candidates for ART, we could speculate that the pre-existing altered methylation in spermatozoa may result in an easier imprinting error during fertilization. So far, several trials evaluated the association between DNA methylation levels and ART outcomes, with conflicting results (Benchaib et al., 2005) (Kobayashi et al., 2017) . The effect of aberrant DNA methylation on ART outcomes is out of the scope of this study but we emphasize its role in male subfertility. Thus, sperm DNA imprinting assessment might be further considered in prospective studies to better clarify an eventual role in the diagnostic flowchart of male infertility, as well as during ART.
The main limitation of our study is as a result of the high heterogeneity of studies evaluating DNA methylation of imprinted genes. Indeed, the 41.6% of included studies enrolled patients with a diagnosis of idiopathic infertility, whereas the remaining part evaluated men with one of the known alteration of semen analysis, from oligozoospermia to OAT. This difference in inclusion criteria justifies the high heterogeneity found in these studies. Aside from these selected studies, several works evaluated the overall DNA methylation in male infertility using a genome-wide approach on sperm DNA (Aston et al., 2015; Camprubi et al., 2016; Du et al., 2016; Jenkins et al., 2016) . These studies confirmed that male infertility could be associated to alterations in the mature epigenome, although each study recognized a specific cluster of genes probably implicated in its pathogenesis. Here, we confirm the association between male infertility and aberrant DNA methylation, at least at H19, MEST and SNRPN level, although specific trials should be designed to identify all genes involved in male infertility. The wide number of imprinted genes possibly involved in male infertility represents a second limitation of our study. Only H19, SNRPN, MEST, and LINE-1 were evaluated in a number of studies sufficient to allow a comprehensive evaluation. Finally, the major challenge to evaluate the role of epigenetic influence on male fertility is represented by the difficult to compare available studies. Indeed, several studies described the DNA methylation level of a specific gene, whereas others reported the proportion of patients with an aberrant DNA methylation, providing not comparable results.
In conclusion, our meta-analytic approach confirms the association between male infertility and reduced sperm H19 methylation and increased MEST and SNRPN methylation. However, specific trials should be designed to evaluate the appropriate role of DNA methylation assessment into the diagnostic flowchart of male infertility. Moreover, considering the high heterogeneity of studies included and the difficulty to compare results of each trial, a clear consensus on the better way to comprehensively report these results in scientific papers is needed.
